Rate of Pharmacotherapy for Tobacco Smoking Cessation in Patients With New Peripheral Artery Disease

This cross-sectional study uses US insurance claims data to examine the rate of varenicline use for tobacco smoking cessation among adults with newly diagnosed peripheral artery disease.

Corresponding Author: Ken R. Cohen, MD, Optum Center for Research and Innovation, 11000 Optum Circle, Eden Prairie, MN 55344 (ken.cohen@optum.com).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.